MTOR and Hyperglycemia: Post-allograft transplant antirejection regimens (glucocorticoids, azathioprine, mycophenolate, calcineurin inhibitors and mTOR inhibitors) may trigger or aggravate hyperglycemia or hyperlipidemia.